Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 1
2006 1
2007 2
2008 3
2009 1
2010 2
2011 2
2012 3
2013 4
2014 6
2015 7
2016 7
2017 3
2018 11
2019 5
2020 12
2021 12
2022 11
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Increased risk for multiple myeloma"
Page 1
Bortezomib for the treatment of multiple myeloma.
Scott K, Hayden PJ, Will A, Wheatley K, Coyne I. Scott K, et al. Cochrane Database Syst Rev. 2016 Apr 20;4(4):CD010816. doi: 10.1002/14651858.CD010816.pub2. Cochrane Database Syst Rev. 2016. PMID: 27096326 Free PMC article. Review.
BACKGROUND: Multiple myeloma is a malignancy of plasma cells accounting for approximately 1% of cancers and 12% of haematological malignancies. ...There is high-quality evidence for increased risk of cardiac disorders from analysing trials of bortezomi …
BACKGROUND: Multiple myeloma is a malignancy of plasma cells accounting for approximately 1% of cancers and 12% of haematologi …
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Renehan AG, et al. Lancet. 2008 Feb 16;371(9612):569-78. doi: 10.1016/S0140-6736(08)60269-X. Lancet. 2008. PMID: 18280327 Review.
We noted weaker positive associations (RR <1.20) between increased BMI and rectal cancer and malignant melanoma in men; postmenopausal breast, pancreatic, thyroid, and colon cancers in women; and leukaemia, multiple myeloma, and non-Hodgkin lymphoma in bot …
We noted weaker positive associations (RR <1.20) between increased BMI and rectal cancer and malignant melanoma in men; postmenopa …
Primary Sjogren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis.
Zhong H, Liu S, Wang Y, Xu D, Li M, Zhao Y, Zeng X. Zhong H, et al. Autoimmun Rev. 2022 May;21(5):103084. doi: 10.1016/j.autrev.2022.103084. Epub 2022 Mar 24. Autoimmun Rev. 2022. PMID: 35341972 Review.
OBJECTIVE: Patients with primary Sjogren's syndrome(pSS) have increased risk of non-Hodgkin lymphoma (NHL). However, whether pSS patients have increased risk of other malignancies is unclear. ...CONCLUSION: This meta-analysis showed that pSS patients h …
OBJECTIVE: Patients with primary Sjogren's syndrome(pSS) have increased risk of non-Hodgkin lymphoma (NHL). However, whether p …
The effects of physical exercise in the palliative care phase for people with advanced cancer: a systematic review with meta-analysis.
Toohey K, Chapman M, Rushby AM, Urban K, Ingham G, Singh B. Toohey K, et al. J Cancer Surviv. 2023 Apr;17(2):399-415. doi: 10.1007/s11764-021-01153-0. Epub 2022 Jan 18. J Cancer Surviv. 2023. PMID: 35040076
Cancer types consisted of lung (n = 6), breast (n = 3), prostate (n = 2), multiple myeloma (n = 1) and mixed cancer types (n = 10). Meta-analysis of 20 RCTs involving 1840 participants showed no difference in the risk of a grade 2-4 adverse event between exer …
Cancer types consisted of lung (n = 6), breast (n = 3), prostate (n = 2), multiple myeloma (n = 1) and mixed cancer types (n = …
Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis.
Reynolds G, Cliff ERS, Mohyuddin GR, Popat R, Midha S, Liet Hing MN, Harrison SJ, Kesselheim AS, Teh BW. Reynolds G, et al. Blood Adv. 2023 Oct 10;7(19):5898-5903. doi: 10.1182/bloodadvances.2023010539. Blood Adv. 2023. PMID: 37467036 Free PMC article.
Bispecific antibodies, a novel immunotherapy with promising efficacy against multiple myeloma, form immune synapses between T-cell surface marker CD3 and malignant cell markers, including B-cell maturation antigen (BCMA), FcRH5, and G protein-coupled receptor GPRC5D …
Bispecific antibodies, a novel immunotherapy with promising efficacy against multiple myeloma, form immune synapses between T- …
Altered Fibrinolysis in Hematological Malignances.
Bønløkke ST, Ommen HB, Hvas AM. Bønløkke ST, et al. Semin Thromb Hemost. 2021 Jul;47(5):569-580. doi: 10.1055/s-0041-1725099. Epub 2021 May 31. Semin Thromb Hemost. 2021. PMID: 34058766
In studies examining fibrinolysis during chemotherapy results were ambiguous. Two studies examining multiple myeloma indicated hypofibrinolysis prior to chemotherapy, and in another plasma cell disease, amyloid light chain-amyloidosis, clear signs of hyperfibrinolys …
In studies examining fibrinolysis during chemotherapy results were ambiguous. Two studies examining multiple myeloma indicated …
Pesticide applicators and cancer: a systematic review.
Varghese JV, Sebastian EM, Iqbal T, Tom AA. Varghese JV, et al. Rev Environ Health. 2020 Dec 10;36(4):467-476. doi: 10.1515/reveh-2020-0121. Print 2021 Dec 20. Rev Environ Health. 2020. PMID: 34821114 Review.
A total of 32 studies were identified among which the average sample size was found to be 60,521. Increased RRs/ORs and positive exposure-response relationships were observed for 31 pesticides. Organophosphate and organochlorine classes of pesticides were the most to be as …
A total of 32 studies were identified among which the average sample size was found to be 60,521. Increased RRs/ORs and positive expo …
Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents.
Kahale LA, Matar CF, Tsolakian I, Hakoum MB, Yosuico VE, Terrenato I, Sperati F, Barba M, Hicks LK, Schünemann H, Akl EA. Kahale LA, et al. Cochrane Database Syst Rev. 2021 Sep 28;9(9):CD014739. doi: 10.1002/14651858.CD014739. Cochrane Database Syst Rev. 2021. PMID: 34582035 Free PMC article. Review.
People with multiple myeloma are treated with immunomodulatory agents including lenalidomide, pomalidomide, and thalidomide. Multiple myeloma is associated with an increased risk of thromboembolism, which appears to be further increase …
People with multiple myeloma are treated with immunomodulatory agents including lenalidomide, pomalidomide, and thalidomide. …
Risk of malignancy in ankylosing spondylitis: a systematic review and meta-analysis.
Deng C, Li W, Fei Y, Li Y, Zhang F. Deng C, et al. Sci Rep. 2016 Aug 18;6:32063. doi: 10.1038/srep32063. Sci Rep. 2016. PMID: 27534810 Free PMC article. Review.
Current knowledge about the overall and site-specific risk of malignancy associated with ankylosing spondylitis (AS) is inconsistent. ...AS is associated with a 14% (pooled RR 1.14; 95% CI 1.03-1.25) increase in the overall risk for malignancy. Compared to co …
Current knowledge about the overall and site-specific risk of malignancy associated with ankylosing spondylitis (AS) is inconsistent. …
Primary Sjogren's syndrome and malignancy risk: a systematic review and meta-analysis.
Liang Y, Yang Z, Qin B, Zhong R. Liang Y, et al. Ann Rheum Dis. 2014 Jun;73(6):1151-6. doi: 10.1136/annrheumdis-2013-203305. Epub 2013 May 17. Ann Rheum Dis. 2014. PMID: 23687261 Review.
Additionally, the number of studies exploring the association of pSS with the risk of solid malignancies was so small that we could not carry out subgroup meta-analyses. CONCLUSIONS: This meta-analysis indicates that pSS is significantly associated with increased ri …
Additionally, the number of studies exploring the association of pSS with the risk of solid malignancies was so small that we could n …
92 results